Knowledge, attitudes, and practices toward chemotherapy resistance among oncologists: a multinational cross-sectional study - Takeaways - MDSpire

Knowledge, attitudes, and practices toward chemotherapy resistance among oncologists: a multinational cross-sectional study

  • By

  • Bassam Abdul Rasool Hassan

  • Ali Haider Mohammed

  • Khalis Mohamed

  • Vladimir Yu. Startsev

  • Chema Drira

  • Omar Hamdy

  • Miada Mohamed Fahmi Elmetwaly

  • Said Nabil

  • Shamma Alshehhi

  • Gamil Othman

  • Hamoud H. Y. Al-Hussaini

  • Ahmed Zuhair Abdulhameed Alsammarraie

  • Arooj Abid

  • Nada M. Kassem

  • Sami El Khatib

  • Souheil Hallit

  • Diana Malaeb

  • Hassan Hosseini

  • June 5, 2026

  • 0 min

Share

  • 1

    The study evaluated oncologists' knowledge, attitudes, and practices regarding chemotherapy resistance across multiple countries.

  • 2

    A total of 3,779 oncologists participated, with a mean age of 36.92 years and a majority being medical oncologists.

  • 3

    Younger oncologists and those with post-doctorate degrees exhibited better knowledge and more positive attitudes towards chemotherapy resistance.

  • 4

    Significant gaps in oncologists' understanding of chemotherapy resistance were identified, necessitating targeted educational programs.

  • 5

    The findings emphasize the need for global strategies to improve the management of chemotherapy resistance in diverse healthcare settings.

Original Source(s)

Knowledge, attitudes, and practices toward chemotherapy resistance among oncologists: a multinational cross-sectional study

  • by Bassam Abdul Rasool Hassan, Ali Haider Mohammed, Khalis Mohamed, Vladimir Yu. Startsev, Chema Drira, Omar Hamdy, Miada Mohamed Fahmi Elmetwaly, Said Nabil, Shamma Alshehhi, Gamil Othman, Hamoud H. Y. Al-Hussaini, Ahmed Zuhair Abdulhameed Alsammarraie, Arooj Abid, Nada M. Kassem, Sami El Khatib, Souheil Hallit, Diana Malaeb, Hassan Hosseini

  • June 5, 2026

Related Content

Targeted therapy in thyroid cancer: molecular alterations and clinical management

Integrative oncology: evolution, framework, and future directions

Mesonephric-like adenocarcinoma of the uterine corpus: a case report